SB 5292 Washington Senate · 2019-2020 Regular Session

Concerning prescription drug cost transparency.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2020

Committee Review

Apr 2019

Senate Passage

Feb 2019

House Passage

Governor

Introduced Jan 13, 2020 Last action Jan 13, 2020

Floor votes · Senate Feb 28, 2019

How they voted

44–0

Passed

Total votes 44

Feb 28, 2019

D Democratic27

27 Yea

100% Yea

R Republican17

17 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 13, 2020

Introduced

By resolution, reintroduced and retained in present status.

upper

Apr 1, 2019

Committee

Referred to Appropriations.

upper

Mar 27, 2019

Lower · Passed

Scheduled for public hearing in the House Committee on Health Care & Wellness at 01:30 PM

lower

Mar 27, 2019

Upper · Passed

HCW - Majority; do pass with amendment(s).

upper

Mar 15, 2019

Lower · Passed

Scheduled for public hearing in the House Committee on Health Care & Wellness at 08:30 AM

lower

Feb 28, 2019

Senate · Passed

Senate Vote: pass (44-0)

senate

Feb 26, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Ways & Means at 01:30 PM

upper

Feb 26, 2019

Upper · Passed

WM - Majority; 2nd substitute bill be substituted, do pass.

upper

Feb 19, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Ways & Means at 03:30 PM

upper

Feb 11, 2019

Committee

Referred to Ways & Means.

upper

Feb 8, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 08:00 AM

upper

Feb 8, 2019

Committee

And refer to Ways & Means.

upper

Feb 8, 2019

Upper · Passed

HLTC - Majority; 1st substitute bill be substituted, do pass.

upper

Jan 28, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 01:30 PM

upper

1 primary · 11 co-sponsors